Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
Authors
Keywords
Ascites, Ovarian cancer, Tumor microenvironment, Cytokines, Inflammation, Drug resistance
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-30
DOI
10.1186/s12885-015-1511-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions
- (2015) Anita Chudecka-Glaz et al. OncoTargets and Therapy
- MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
- (2014) Isabelle Matte et al. BMC CANCER
- Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation
- (2014) Hong Qiong Yan et al. CANCER SCIENCE
- MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
- (2014) Mildred Felder et al. Molecular Cancer
- Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
- (2013) Denis Lane et al. Journal of Ovarian Research
- Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
- (2013) Jeremy Chien et al. Frontiers in Oncology
- The role of interleukin-6 in gynaecological malignancies
- (2012) Jermaine I.G. Coward et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
- (2012) Sharon Cohen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
- (2012) Nadzeya Goncharenko-Khaider et al. Molecular Cancer
- Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
- (2012) He Huang et al. PLoS One
- Integrated Analysis of Gene Expression Profiles Associated with Response of Platinum/Paclitaxel-Based Treatment in Epithelial Ovarian Cancer
- (2012) Yong Han et al. PLoS One
- Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
- (2012) Denis Lane et al. Journal of Ovarian Research
- Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
- (2011) Denis Lane et al. BMC CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells
- (2011) I Lakshmanan et al. ONCOGENE
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
- (2011) Rafael Molina et al. TUMOR BIOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines
- (2010) Li Zeng et al. CYTOKINE
- Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis
- (2010) Mian M. K. Shahzad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation
- (2010) D Lane et al. ONCOGENE
- The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer
- (2010) Denis Lane et al. Journal of Ovarian Research
- CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis
- (2009) Marianne Boivin et al. GYNECOLOGIC ONCOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Mining the plasma proteome for cancer biomarkers
- (2008) Samir M. Hanash et al. NATURE
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search